Literature DB >> 33293271

Longitudinal analysis of microvascular perfusion and neurodegenerative changes in early type 2 diabetic retinal disease.

Julia Aschauer1, Andreas Pollreisz1, Sonja Karst1, Martin Hülsmann2, Dorottya Hajdu1, Felix Datlinger1, Berit Egner1, Katharina Kriechbaum1, Eleonore Pablik3, Ursula Margarethe Schmidt-Erfurth4.   

Abstract

AIM: To prospectively monitor subclinical changes in capillary perfusion and retinal layer thickness in patients with type 2 diabetes and early diabetic retinal disease over 2 years.
METHODS: In this longitudinal study we performed biannual retinal vascular imaging using optical coherence tomography angiography (RTVue) to analyse the foveal avascular zone (FAZ) area, perimeter, acircularity index (AI) and parafoveal superficial/deep vessel density (VD). Spectral-domain optical coherence tomography (Spectralis) was used to measure the thickness of nine macular layers and the peripapillary nerve fibre layer.
RESULTS: Among 117 eyes (58 left) of 59 patients (21 female), 105 had no diabetic retinopathy (DR), 6 mild and 6 moderate non-proliferative DR at baseline. We found DR progression in 13 eyes at year 2. The FAZ area (+0.008±0.002 mm2/year, p<0.0001), perimeter (+0.036±0.010 mm/year, p=0.006) and AI (+0.005±0.002/year, p=0.0280) increased significantly. A pronounced decrease was found in the superficial (-1.425±0.290%/year, p<0.0001) but not the deep VD. Inner neuroretinal loss was confined to the ganglion cell (-0.539±0.150 µm/year, p=0.0004) and the inner plexiform layer (-0.361±0.127 µm/year, p=0.0045). In the outer retina, we observed a statistically significant decrease in thickness in the outer plexiform, photoreceptor layer and pigment epithelium of -0.921±0.161 µm/year, -0.325±0.139 µm/year and -0.385±0.084 µm/year, respectively.
CONCLUSION: Subclinical signs of microangiopathy and neurodegeneration appear in parallel and are highly progressive even in the earliest stages of diabetic retinal disease. Trial registration number EudraCT20156000239634. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  retina

Mesh:

Year:  2020        PMID: 33293271     DOI: 10.1136/bjophthalmol-2020-317322

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

Review 1.  Retinal Neurodegeneration in Diabetes: an Emerging Concept in Diabetic Retinopathy.

Authors:  Mira M Sachdeva
Journal:  Curr Diab Rep       Date:  2021-12-13       Impact factor: 4.810

2.  Retinal Neurodegeneration in Different Risk Phenotypes of Diabetic Retinal Disease.

Authors:  Maria H Madeira; Inês P Marques; Sónia Ferreira; Diana Tavares; Torcato Santos; Ana Rita Santos; João Figueira; Conceição Lobo; José Cunha-Vaz
Journal:  Front Neurosci       Date:  2021-12-21       Impact factor: 5.152

3.  Association between Neurodegeneration and Macular Perfusion in the Progression of Diabetic Retinopathy: A 3-Year Longitudinal Study.

Authors:  Inês P Marques; Sónia Ferreira; Torcato Santos; Maria H Madeira; Ana Rita Santos; Luís Mendes; Conceição Lobo; José Cunha-Vaz
Journal:  Ophthalmologica       Date:  2022-02-14       Impact factor: 3.757

4.  Detecting retinal neurodegeneration in people with diabetes: Findings from the UK Biobank.

Authors:  Roomasa Channa; Kyungmoo Lee; Kristen A Staggers; Nitish Mehta; Sidra Zafar; Jie Gao; Benjamin J Frankfort; Sharon Y L Chua; Anthony P Khawaja; Paul J Foster; Praveen J Patel; Charles G Minard; Chris Amos; Michael D Abramoff
Journal:  PLoS One       Date:  2021-09-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.